Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Barth

Showing results (71-80 of 152) with videos related to

Pageof 16
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1990
Distinct and non-cross-reactive epitopes are recognized on B16 melanoma by LAK cells and anti-B16 monoclonal antibodiesJ J Tzeng, R F Barth, C W Johnson, et al.
Journal of the National Cancer Institute|April 1, 1981
Relationship between concanavalin A-induced agglutinability of murine leukemia cells and their propensity to form heterotypic aggregates with syngeneic lymphoid cellsG P Phondke, K R Madyastha, P R Madyastha, et al.
Journal of the National Cancer Institute|April 1, 1981
Quantitative assay for lectin-induced cytoagglutination by means of an electronic particle-counting techniqueG P Phondke, K R Madyastha, P R Madyastha, et al.
Hybridoma|July 1, 1986
Boronated monoclonal antibody 17-1A for potential neutron capture therapy of colorectal cancerR F Barth, F Alam, A H Soloway, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 27, 2009
Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agentsW Yang, R F Barth, G Wu, et al.
Anticancer Research|January 1, 1996
In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapyL Liu, R F Barth, W Tjarks, et al.
Basic Life Sciences|January 1, 1989
Boron compounds for neutron capture therapyF Alam, A H Soloway, B V Bapat, et al.
Carcinogenesis|August 1, 1989
Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in ratsC Dwivedi, O A Oredipe, R F Barth, et al.
Bioconjugate Chemistry|January 1, 1994
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapyR F Barth, D M Adams, A H Soloway, et al.
Transplantation Proceedings|March 1, 1979
Neutrophilic blasts associated with human renal allograft rejectionJ Clancy, J H Thomas, G E Pierce, et al.
Pageof 16

Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1990
Distinct and non-cross-reactive epitopes are recognized on B16 melanoma by LAK cells and anti-B16 monoclonal antibodiesJ J Tzeng, R F Barth, C W Johnson, et al.
Journal of the National Cancer Institute|April 1, 1981
Relationship between concanavalin A-induced agglutinability of murine leukemia cells and their propensity to form heterotypic aggregates with syngeneic lymphoid cellsG P Phondke, K R Madyastha, P R Madyastha, et al.
Journal of the National Cancer Institute|April 1, 1981
Quantitative assay for lectin-induced cytoagglutination by means of an electronic particle-counting techniqueG P Phondke, K R Madyastha, P R Madyastha, et al.
Hybridoma|July 1, 1986
Boronated monoclonal antibody 17-1A for potential neutron capture therapy of colorectal cancerR F Barth, F Alam, A H Soloway, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 27, 2009
Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agentsW Yang, R F Barth, G Wu, et al.
Anticancer Research|January 1, 1996
In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapyL Liu, R F Barth, W Tjarks, et al.
Basic Life Sciences|January 1, 1989
Boron compounds for neutron capture therapyF Alam, A H Soloway, B V Bapat, et al.
Carcinogenesis|August 1, 1989
Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in ratsC Dwivedi, O A Oredipe, R F Barth, et al.
Bioconjugate Chemistry|January 1, 1994
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapyR F Barth, D M Adams, A H Soloway, et al.
Transplantation Proceedings|March 1, 1979
Neutrophilic blasts associated with human renal allograft rejectionJ Clancy, J H Thomas, G E Pierce, et al.
Pageof 16